Vietnam steps up measures to prevent African swine fever

Vietnamese authorities on Wednesday conducted drills to prevent the spread of African swine fever should there be an outbreak of the disease in the country, as the risks of transmission from neighboring China increase.

Bayer halts vilaprisan drug trials due to toxicology data

Bayer said it halted trials testing its experimental uterine fibroids treatment vilaprisan, which it previously expected to generate peak annual sales of more than 1 billion euros ($1.1 billion), citing the risk of side effects.

More U.S. pregnant women using opioids and meth

(Reuters Health) – A growing number of American pregnant women are using opioids and methamphetamines, and drug use is rising fastest among mothers in rural communities, a U.S. study suggests.

U.S. judge concerned over government nod for CVS-Aetna deal

A federal judge who has been asked to sign off on the U.S. government’s decision to approve CVS Health Corp’s acquisition of insurer Aetna Inc said Tuesday he was “less convinced” than the government that the companies had struck a deal that ensured the merger was legal under antitrust law.

U.S. relies heavily on foreign-born healthcare workers

(Reuters Health) – More than one in four doctors in the United States were born in another country, and a new study suggests many nurses, dentists, pharmacists, and home health aides are also immigrants.

Novartis’s new treatment for hives outperforms Xolair in trials

Novartis said on Tuesday it was taking its experimental medicine ligelizumab to late-stage trials after the drug showed signs of outperforming existing product Xolair in treating severe urticaria, also known as hives.

Amgen antibody shows promise in myeloma trial, gets FDA fast track

Amgen Inc, updating the first trial of its bispecific antibody for multiple myeloma, said on Monday seven out of 10 patients given the second-highest dose of AMG420 responded to the drug, including four with no detectable cancer.